Drugs inhibiting the quorum-sensing of bacteria Staphylococcus aureus

Authors

А.Е. Abaturov State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine”, Dnipro, Ukraine http://orcid.org/0000-0001-6291-5386
Т.А. Kryuchko Ukrainian Medical Stomatological Academy, Poltava, Ukraine

DOI:

https://doi.org/10.22141/2224-0551.14.3.2019.168803

Keywords:

quorum sensing, Staphylococcus aureus, inhibitors of quorum sensing, review

Abstract

The scientific review presents data on the functioning of the quorum-sensing systems Agr and RAP/TRAP of Staphylococcus aureus bacteria. The paper gives the characteristics of medications inhibiting the export of AIP from a bacterial cell, the activity of histidine kinase AgrC, the expression and functional activity of AgrA, the expression of the RNAIII transcript of Staphylococcus aureus bacteria. It is suggested that the drugs developed to inhibit the activity of the mechanisms of the quorum sensing of Staphylococcus aureus bacteria will take a worthy place in anti-staphylococcal therapy.

Downloads

Download data is not yet available.

References

Abaturov OE, Volosovets AP, Yulish YeI. The role of Toll-like receptors in pathogen-associated molecular rectification of infectious pathogenic agents in the development of inflammation; Part 1: The TLR family. Zdorov`e rebenka. 2012;(40):116-121.

Balaban N, Cirioni O, Giacometti A, et al. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Antimicrob Agents Chemother. 2007 Jun;51(6):2226-9. doi: 10.1128/AAC.01097-06.

Baldassarre L, Fornasari E, Cornacchia C, et al. Discovery of novel RIP derivatives by alanine scanning for the treatment of S. aureus infections. Med Chem Comm. 2013;4:1114-1117. doi: 10.1039/C3md00122a.

Baldry M, Kitir B, Frøkiær H, et al. The agr Inhibitors Solonamide B and Analogues Alter Immune Responses to Staphylococccus aureus but Do Not Exhibit Adverse Effects on Immune Cell Functions. PLoS One. 2016 Jan 5;11(1):e0145618. doi: 10.1371/journal.pone.0145618.

Bröker BM, Holtfreter S, Bekeredjian-Ding I. Immune control of Staphylococcus aureus - regulation and counter-regulation of the adaptive immune response. Int J Med Microbiol. 2014 Mar;304(2):204-14. doi: 10.1016/j.ijmm.2013.11.008.

Quave CL, Horswill AR. Flipping the switch: tools for detecting small molecule inhibitors of staphylococcal virulence. Front Microbiol. 2014 Dec 12;5:706. doi: 10.3389/fmicb.2014.00706.

Cullen L, McClean S. Bacterial Adaptation during Chronic Respiratory Infections. Pathogens. 2015 Mar 2;4(1):66-89. doi: 10.3390/pathogens4010066.

Da F, Yao L, Su Z, et al. Antisense locked nucleic acids targeting agrA inhibit quorum sensing and pathogenesis of community-associated methicillin-resistant Staphylococcus aureus. J Appl Microbiol. 2017 Jan;122(1):257-267. doi: 10.1111/jam.13321.

Desouky SE, Shojima A, Singh RP, et al. Cyclodepsipeptides produced by actinomycetes inhibit cyclic-peptide-mediated quorum sensing in Gram-positive bacteria. FEMS Microbiol Lett. 2015 Jul;362(14). pii: fnv109. doi: 10.1093/femsle/fnv109.

Doulgeraki AI, Di Ciccio P, Ianieri A, Nychas GE. Methicillin-resistant food-related Staphylococcus aureus: a review of current knowledge and biofilm formation for future studies and applications. Res Microbiol. 2017 Jan;168(1):1-15. doi: 10.1016/j.resmic.2016.08.001.

Habboush Y, Guzman N. Antibiotic Resistance. Treasure Island (FL): StatPearls Publishing; 2018.

Hansen AM, Peng P, Baldry M, et al. Lactam hybrid analogues of solonamide B and autoinducing peptides as potent S. aureus AgrC antagonists. Eur J Med Chem. 2018 May 25;152:370-376. doi: 10.1016/j.ejmech.2018.04.053.

Hernández-Aquino E, Muriel P. Beneficial effects of naringenin in liver diseases: Molecular mechanisms. World J Gastroenterol. 2018 Apr 28;24(16):1679-1707. doi: 10.3748/wjg.v24.i16.1679.

Igarashi Y, Gohda F, Kadoshima T, et al. Avellanin C, an inhibitor of quorum-sensing signaling in Staphylococcus aureus, from Hamigera ingelheimensis. J Antibiot (Tokyo). 2015 Nov;68(11):707-10. doi: 10.1038/ja.2015.50.

Junie LM, Jeican II, Matroş 1, Pandrea SL, et al. Molecular epidemiology of the community-associated methicillin-resistant staphylococcus aureus clones: a synthetic review. Clujul Med. 2018;91(1):7-11. doi: 10.15386/cjmed-807.

Karathanasi G, Bojer MS, Baldry M, et al. Linear peptidomimetics as potent antagonists of Staphylococcus aureus agr quorum sensing. Sci Rep. 2018 Feb 23;8(1):3562. doi: 10.1038/s41598-018-21951-4.

Khodaverdian V, Pesho M, Truitt B, et al. Discovery of antivirulence agents against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2013 Aug;57(8):3645-52. doi: 10.1128/AAC.00269-13.

Kumburu HH, Sonda T, Leekitcharoenphon P, et al. Hospital Epidemiology of Methicillin-Resistant Staphylococcus aureus in a Tertiary Care Hospital in Moshi, Tanzania, as Determined by Whole Genome Sequencing. Biomed Res Int. 2018 Jan 2;2018:2087693. doi: 10.1155/2018/2087693.

Le KY, Otto M. Quorum-sensing regulation in staphylococci-an overview. Front Microbiol. 2015 Oct 27;6:1174. doi: 10.3389/fmicb.2015.01174.

Lee K, Lee JH, Kim SI, Cho MH, Lee J. Anti-biofilm, anti-hemolysis, and anti-virulence activities of black pepper, cananga, myrrh oils, and nerolidol against Staphylococcus aureus. Appl Microbiol Biotechnol. 2014 Nov;98(22):9447-57. doi: 10.1007/s00253-014-5903-4.

Li J, Wang W, Xu SX, Magarvey NA, McCormick JK. Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3360-5. doi: 10.1073/pnas.1017431108.

Madden GR, Sifri CD. Antimicrobial Resistance to Agents Used for Staphylococcus aureus Decolonization: Is There a Reason for Concern? Curr Infect Dis Rep. 2018 Jun 7;20(8):26. doi: 10.1007/s11908-018-0630-0.

Murray EJ, Crowley RC, Truman A, et al. Targeting Staphylococcus aureus quorum sensing with nonpeptidic small molecule inhibitors. J Med Chem. 2014 Mar 27;57(6):2813-9. doi: 10.1021/jm500215s.

Novick RP, Geisinger E. Quorum sensing in staphylococci. Annu Rev Genet. 2008;42:541-64. doi: 10.1146/annurev.genet.42.110807.091640.

Pollitt EJ, West SA, Crusz SA, Burton-Chellew MN, Diggle SP. Cooperation, quorum sensing, and evolution of virulence in Staphylococcus aureus. Infect Immun. 2014 Mar;82(3):1045-51. doi: 10.1128/IAI.01216-13.

Simonetti O, Cirioni O, Cacciatore I, et al. Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound. PLoS One. 2016 Jun 2;11(6):e0151956. doi: 10.1371/journal.pone.0151956.

Singh R, Ray P. Quorum sensing-mediated regulation of staphylococcal virulence and antibiotic resistance. Future Microbiol. 2014;9(5):669-81. doi: 10.2217/fmb.14.31.

Solano C, Echeverz M, Lasa I. Biofilm dispersion and quorum sensing. Curr Opin Microbiol. 2014 Apr;18:96-104. doi: 10.1016/j.mib.2014.02.008.

Sully EK, Malachowa N, Elmore BO, et al. Selective chemical inhibition of agr quorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance. PLoS Pathog. 2014 Jun 12;10(6):e1004174. doi: 10.1371/journal.ppat.1004174.

Tal-Gan Y, Stacy DM, Foegen MK, Koenig DW, Blackwell HE. Highly potent inhibitors of quorum sensing in Staphylococcus aureus revealed through a systematic synthetic study of the group-III autoinducing peptide. J Am Chem Soc. 2013 May 29;135(21):7869-82. doi: 10.1021/ja3112115.

Tal-Gan Y, Stacy DM, Blackwell HE. N-Methyl and peptoid scans of an autoinducing peptide reveal new structural features required for inhibition and activation of AgrC quorum sensing receptors in Staphylococcus aureus. Chem Commun (Camb). 2014 Mar 21;50(23):3000-3. doi: 10.1039/c4cc00117f.

Tan L, Li SR, Jiang B, Hu XM, Li S. Therapeutic Targeting of the Staphylococcus aureus Accessory Gene Regulator (agr) System. Front Microbiol. 2018 Jan 25;9:55. doi: 10.3389/fmicb.2018.00055.

Todd DA, Zich DB, Ettefagh KA, Kavanaugh JS, Horswill AR, Cech NB. Hybrid Quadrupole-Orbitrap mass spectrometry for quantitative measurement of quorum sensing inhibition. J Microbiol Methods. 2016 Aug;127:89-94. doi: 10.1016/j.mimet.2016.05.024.

Todd DA, Parlet CP, Crosby HA, et al. Signal Biosynthesis Inhibition with Ambuic Acid as a Strategy To Target Antibiotic-Resistant Infections. Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00263-17. doi: 10.1128/AAC.00263-17.

Tsuchikama K, Shimamoto Y, Anami Y. Truncated Autoinducing Peptide Conjugates Selectively Recognize and Kill Staphylococcus aureus. ACS Infect Dis. 2017 Jun 9;3(6):406-410. doi: 10.1021/acsinfecdis.7b00013.

Turkey AM, Barzani KK2, Suleiman AAJ, Abed JJ. Molecular assessment of accessory gene regulator (agr) quorum sensing system in biofilm forming Staphylococcus aureus and study of the effect of silver nanoparticles on agr system. Iran J Microbiol. 2018 Feb;10(1):14-21.

Vasquez JK, Tal-Gan Y, Cornilescu G, Tyler KA, Blackwell HE. Simplified AIP-II Peptidomimetics Are Potent Inhibitors of Staphylococcus aureus AgrC Quorum Sensing Receptors. Chembiochem. 2017 Feb 16;18(4):413-423. doi: 10.1002/cbic.201600516.

Vermote A, Brackman G, Risseeuw MD, et al. Hamamelitannin Analogues that Modulate Quorum Sensing as Potentiators of Antibiotics against Staphylococcus aureus. Angew Chem Int Ed Engl. 2016 May 23;55(22):6551-5. doi: 10.1002/anie.201601973.

Vermote A, Brackman G, Risseeuw MDP, Coenye T, Van Calenbergh S. Novel hamamelitannin analogues for the treatment of biofilm related MRSA infections-A scaffold hopping approach. Eur J Med Chem. 2017 Feb 15;127:757-770. doi: 10.1016/j.ejmech.2016.10.056.

Walz JM, Avelar RL, Longtine KJ, Carter KL, Mermel LA, Heard SO; 5-FU Catheter Study Group. Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization. Crit Care Med. 2010 Nov;38(11):2095-102. doi: 10.1097/CCM.0b013e3181f265ba.

Wang B, Muir TW. Regulation of Virulence in Staphylococcus aureus: Molecular Mechanisms and Remaining Puzzles. Cell Chem Biol. 2016 Feb 18;23(2):214-24. doi: 10.1016/j.chembiol.2016.01.004.

Wang LH, Zeng XA, Wang MS, Brennan CS, Gong D. Modification of membrane properties and fatty acids biosynthesis-related genes in Escherichia coli and Staphylococcus aureus: Implications for the antibacterial mechanism of naringenin. Biochim Biophys Acta. 2018 Feb;1860(2):481-490. doi: 10.1016/j.bbamem.2017.11.007.

Washam M, Woltmann J, Haberman B, Haslam D, Staat MA. Risk factors for methicillin-resistant Staphylococcus aureus colonization in the neonatal intensive care unit: A systematic review and meta-analysis. Am J Infect Control. 2017 Dec 1;45(12):1388-1393. doi: 10.1016/j.ajic.2017.06.021.

Zhang Y, Wang JF, Dong J, et al. Inhibition of α-toxin production by subinhibitory concentrations of naringenin controls Staphylococcus aureus pneumonia. Fitoterapia. 2013 Apr;86:92-9. doi: 10.1016/j.fitote.2013.02.001.

Zhou Y, Zhao R, Ma B, et al. Oligomerization of RNAIII-Inhibiting Peptide Inhibits Adherence and Biofilm Formation of Methicillin-Resistant Staphylococcus aureus In Vitro and In Vivo. Microb Drug Resist. 2016 Apr;22(3):193-201. doi: 10.1089/mdr.2015.0170.

Downloads

PDF (Українська)

Published

2021-09-10

How to Cite

Abaturov А., & Kryuchko Т. (2021). Drugs inhibiting the quorum-sensing of bacteria Staphylococcus aureus. CHILD`S HEALTH, 14(3), 189–198. https://doi.org/10.22141/2224-0551.14.3.2019.168803

Download Citation

Issue

Vol. 14 No. 3 (2019)

Section

Review of Literature

License

Copyright (c) 2019 А.Е. Abaturov, Т.А. Kryuchko

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)

А.Е. Abaturov, Bacterial surfactants as agents with antibiofilm activity , CHILD`S HEALTH: Vol. 16 No. 1 (2021)
А.Е. Abaturov, Polysaccharide-degrading enzymes as agents dispersing bacterial biofilms , CHILD`S HEALTH: Vol. 15 No. 4 (2020)
А.Е. Abaturov, Nucleases that degrade extracellular DNA of bacterial biofilms , CHILD`S HEALTH: Vol. 15 No. 5 (2020)
А.Е. Abaturov, O.O. Rusakova, Antibiofilm effects of mucolytic drugs , CHILD`S HEALTH: Vol. 15 No. 6 (2020)
А.Е. Abaturov, Anti-biofilm activity of anti-matrix molecules , CHILD`S HEALTH: Vol. 15 No. 8 (2020)
А.Е. Abaturov, Т.А. Kryuchko, Dispersion of bacterial biofilm and chronization of respiratory tract infection , CHILD`S HEALTH: Vol. 14 No. 5 (2019)
А.Е. Abaturov, Proteases that degrade the biofilm matrix , CHILD`S HEALTH: Vol. 15 No. 3 (2020)
А.Е. Abaturov, Т.А. Kryuchko, Drug limitation of the availability of iron ions for pathogenic bacteria (part 1) , CHILD`S HEALTH: Vol. 13 No. 4 (2018)
А.Е. Abaturov, Drug control of biofilm dispersion due to regulation of the activity of bacterial cyclic guanosine monophosphate (part 1) , CHILD`S HEALTH: Vol. 15 No. 1 (2020)
А.Е. Abaturov, Т.А. Kryuchko, Medication-induced inhibition of the activity of sensing quorum of Pseudomonas aeruginosa bacteria , CHILD`S HEALTH: Vol. 14 No. 4 (2019)

1 2 3 > >>